Search Results for: jama

Striking FDA Hahn & Marks JAMA pub on regenerative clinics

Dr-Stephen-Hahn-Commissioner-of-FDA

It was fascinating to read a new JAMA piece by the FDA on unproven stem cell clinics and other regenerative medicine firms. Many of these guys are profiteering off of buzz about exciting, but mostly unproven technologies. While the JAMA opinion piece reiterates the agency’s commitment to evidence-based regenerative medicine, it also makes some other …

Striking FDA Hahn & Marks JAMA pub on regenerative clinics Read More »

Full page JAMA ad from FDA warns docs on foreign drugs

FDA-JAMA-Ad-768x10241

I opened the most recent edition of Journal of the American Medical Association (JAMA) and found a striking full-page ad from the FDA. It’s unclear if this is the first ever such advertisement. I have been unable to find a similar one on the Internet at least. Has anyone seen such ads before? The JAMA …

Full page JAMA ad from FDA warns docs on foreign drugs Read More »

Why I’m planning to get a COVID-19 RNA vaccine: low, mostly theoretical risks

moderna covid 19 rna vaccine study

I’m not a virologist, but I’m still getting asked these days about what the risks might be from the new generation of RNA vaccines for COVID-19. Approaching this question instead as a biologist and genetics/genomics researcher, I can see a handful of at least hypothetical risks. Below I discuss these possible risks and why I’m …

Why I’m planning to get a COVID-19 RNA vaccine: low, mostly theoretical risks Read More »

Recommended reads: Yamanaka review, stem cell indictment, COVID, MYC, more

Paolo-Macchiarini

Here are some recommended stem cell and other reads for the week ranging from COVID developments to prosecutors finally catching up with a stem cell surgeon who had many patients die to a list of interesting pubs. Because Trump now has COVID, I wondered on Friday if he might consider trying unproven stem cells or …

Recommended reads: Yamanaka review, stem cell indictment, COVID, MYC, more Read More »

Upbeat Burt team pub on stem cells for MS comes with uneasy back story

Types-of-Multiple-Sclerosis

Stem cells for MS? How promising is that? A new paper gives stronger reason for hope, but unfortunately this story is more complex than it seems on first glance. New Paper The idea of using a stem cell-related approach to treat multiple sclerosis (MS) has been around for a long time holding major promise, but …

Upbeat Burt team pub on stem cells for MS comes with uneasy back story Read More »

Cool stem cell papers: antibody reprogramming, organoids, gravity, & more

gut-organoid

The past few weeks have brought some exciting, thought-provoking stem cell papers and developments in the regenerative medicine field. Here’s a list of stem cell papers in the media that struck me as particularly cool along with some other developments in the field. Human Stem Cells Fight Parkinson’s Disease in Monkeys Organoids Reveal Clues to Gut-Brain …

Cool stem cell papers: antibody reprogramming, organoids, gravity, & more Read More »

Burt Northwestern Stem Cell MS Trial Part 2: Marketing ‘Cure’-Like Outcomes?

stem-cells-MS-Northwestern-University

Can science now cure MS in some patients with stem cells or is that near on the horizon? What about stem cells for other serious autoimmune disorders? What are the risks to patients in terms of health, money, and hope? What if patients must find $100,000 or $200,000 just to get into a clinical trial for …

Burt Northwestern Stem Cell MS Trial Part 2: Marketing ‘Cure’-Like Outcomes? Read More »

In Depth Report from April 29th Paris Human Gene Edit Meeting

Paris-Gene-Editing-Meeting

Editor’s note. Caroline Simons attended both the April 28th (see her report on that here) and 29th Paris meetings on human gene editing/genetic modification. Today, we have her in depth report on the April 29th meeting. I have posted her piece in full with only minor edits. If you are in a rush you can …

In Depth Report from April 29th Paris Human Gene Edit Meeting Read More »